Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

China flag China · Delayed Price · Currency is CNY
26.28
+0.10 (0.38%)
Mar 10, 2026, 11:29 AM CST
10.10%
Market Cap 11.28B
Revenue (ttm) 3.77B
Net Income (ttm) 571.60M
Shares Out 431.05M
EPS (ttm) 1.33
PE Ratio 19.67
Forward PE 17.28
Dividend 0.62 (2.35%)
Ex-Dividend Date Aug 8, 2025
Volume 1,594,495
Average Volume 4,760,582
Open 26.21
Previous Close 26.18
Day's Range 26.20 - 26.48
52-Week Range 23.62 - 31.46
Beta 0.41
RSI 34.07
Earnings Date Apr 25, 2026

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as... [Read more]

Sector Healthcare
Founded 1582
Employees 2,654
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600993
Full Company Profile

Financial Performance

In 2024, SHA:600993's revenue was 3.73 billion, an increase of 18.85% compared to the previous year's 3.14 billion. Earnings were 528.09 million, an increase of 19.14%.

Financial Statements

News

There is no news available yet.